Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Fierce Biotech
BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech at $1.25 billion.
James Waldron
Jun 12, 2025 8:17am
Fierce Biotech
Regeneron’s $256M bid wins 23andMe bankruptcy auction
May 19, 2025 10:37am
Bluebird investor reluctance pays off with better buyout offer
May 14, 2025 10:40am
CDMO Famar to acquire sterile manufacturing plant in Germany
May 14, 2025 9:33am
Bluebird warns of potential bankruptcy amid buyout delay
May 13, 2025 9:56am
Analysts see M&A surge on the horizon in 2025
May 1, 2025 3:45pm
